
FDA warns consumers not to use Blue Steel and Hero products

The California Board of Pharmacy has announced that it will delay implementation of its electronic pedigree requirements until 2011.

FDA issues draft guidelines for drug-eluting stents

In a Federal Register notice, the Food & Drug Administration is seeking comments regarding prescription drug authentication

ClearScript looks to expand its medication therapy management program to employer health plans.

Medtronic recalls SynchroMed EL, SynchroMed II, and IsoMed implantable pumps

Scientific Protein Laboratories issues recall of heparin sodium active pharmaceutical ingredient

Rite Aid stores market Identigene's retail over-the-counter DNA paternity test kit

Another group, the Pharmaceutical Research & Manufacturers of America, is going green

Bryant Ranch Prepack prescription prepacker for physicians opens larger facility

Companies not fully tapping potential of onsite health centers

Study shows most adults use non-prescription medications for themselves and their children

New study unveiled at GPhA meeting reveals costs of savings from biogeneric drugs

Cedars-Sinai Medical Center must pay a fine of $25,000 for drug errors related to heparin overdose

A Press Ganey Associates report reveals which patients are most and least satisfied with their hospitals.

Cardinal Health and GE Healthcare are partnering to expand the distribution of the imaging agent Myoview.

The Agency for Healthcare Research & Quality issues instructions for creating pill cards to improve patient adherence.

Generics and pharmacy's bottom line.

The National Association of Boards of Pharmacy applauds President Bush for focusing on illegal Internet sales of prescription drugs

Safeway offers immunization to help prevent shingles

Arizona Senate approves smoking cessation treatments for state Medicaid beneficiaries

Tiotropium bromide is associated with possible increased risk of stroke

Congress informs CMS that Medicare durable medical equipment bidding program may harm small businesses

CVS reaches $36.7 million settlement agreement on retail dispensing practices for ranitidine.

USP glycerin monograph updated

Anthracycline extravasation gains new ICD-9-CM code

Fougera and Protherics announce increased DigiFab production to counteract shortage.

VA putting pharmacies on the road during emergencies

The Drug Enforcement Administration is moving three anabolic steroid products out of Schedule III status.